Analystreport

Clearside Biomedical, Inc. (NASDAQ: CLSD) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating.

Clearside Biomedical, Inc.  (CLSD) 
Last clearside biomedical, inc. earnings: 3/11 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.clearsidebio.com/investor-overview